Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Gel 2% in Pediatric Squint Surgery
NCT04859062Completed
- Sponsor
- Research Institute of Ophthalmology
- Start
- Aug 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of lidocaine 10% oropharyngeal spray in strabismus (2 arms), sponsored by Research Institute of Ophthalmology. Primary endpoints: Postoperative pain after recovery in PACU using FLACC score and Need for postoperative systemic analgesia. Started Aug 2021; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
strabismus
Beyond the preview
Go deeper on NCT04859062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04859062.